Skip to product information
1 of 1

Elabscience

SKU:PKSR030489

Recombinant 2019-nCoV S-trimer Protein (His Tag)

Recombinant 2019-nCoV S-trimer Protein (His Tag)

Regular price $415.00 USD
Regular price Sale price $415.00 USD
Sale Sold out
Shipping calculated at checkout.
Size
Introducing the Recombinant 2019-nCoV S-Trimer Protein (HIS TAG), a cutting-edge product meticulously engineered to cater to the ever-evolving demands of the scientific community. This protein, derived from the novel coronavirus SARS-CoV-2, showcases an exceptional level of purity and functionality, making it an invaluable tool for various research applications.

Crafted through advanced recombinant DNA technology, this protein exhibits a trimeric structure, accurately mimicking the native spike protein found on the surface of the 2019-nCoV virus. Its high affinity for the ACE2 receptor enables precise investigations into viral entry mechanisms, facilitating a deeper understanding of the pathogenesis and aiding in the development of effective therapeutic interventions.

The inclusion of a HIS tag further enhances the versatility of this protein, allowing for facile purification and subsequent downstream applications. This tag, consisting of a sequence of histidine residues, enables efficient immobilization and purification via affinity chromatography techniques, ensuring the isolation of a highly pure and bioactive protein.

Our Recombinant 2019-nCoV S-Trimer Protein (HIS TAG) is meticulously manufactured under stringent quality control measures, guaranteeing exceptional batch-to-batch consistency and reproducibility. Each vial contains a generous quantity of this protein, providing researchers with ample material for their investigations.

With its unrivaled purity, functionality, and ease of use, the Recombinant 2019-nCoV S-Trimer Protein (HIS TAG) stands as an indispensable asset for scientists and researchers striving to unravel the intricacies of the 2019-nCoV virus. Embrace this cutting-edge tool and unlock new frontiers in the fight against the global pandemic.
View full details